MPT Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 6.02%, SMA50 10.15%, SMA200 19.18%). The stock’s 14-day RSI is 60.63 (firm momentum), while the ATR of 0.22 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -10.2% below its high and over 47.09% above its low. Average 10-day trading volume of 4.68 million shares is below the 3-month average of 6.59 million, indicating normal recent market interest.

Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 0 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $5.00 to $5.00. The high target offers -4.4% upside. The low target suggests -4.4% downside. The mean target is $5.00. This offers -4.4% upside. Medical Properties Trust, Inc. earnings surprise history is a mixed track record. The quarter that ended October 30, 2025, missed forecasts by -18.75%. The prior quarter beat by -6.67%. Over the last six quarters, Apple has recorded several small beats. These include 12.5% in February 27, 2025.

Medical Properties Trust, Inc. has 601.50 million shares outstanding. The public float is 490.50 million shares, elevated short interest at 33.16% of float. This equals 138.96 million shares. The short ratio is 23.25 days.

Medical Properties Trust, Inc. (NYSE:MPT) closed at $5.21 USD, losing -$0.02 (-0.29%) from the previous close of $5.23. The stock is currently mid-range between its 52-week high and low $3.95 and $6.47. With a market capitalization of about $15.42 billion, Medical Properties Trust, Inc. is classified as a large-cap and shows higher-than-market volatility (beta ~1.50). Key stats such as the average daily volume over the past year has been around 6.39 million shares, volume is running light vs its 52-week average. Headquartered in Birmingham, AL, Medical Properties Trust, Inc. operates in the Financial Services sector and the REIT - Industrial industry. Led by CEO Edward K. Aldag Jr., the company employs approximately 118 people and listed since December 28, 2007. Medical Properties Trust, Inc. is a self-advised real estate investment trust.

Medical Properties Trust, Inc. last paid a dividend of 0.34 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.35. This means the shares are trading above this model’s fair value.

currently trading near 52-week highs band. Valuation shows Medical Properties Trust, Inc. trading at a premium to the broader market with a P/E of -11.34. Analyst sentiment is cautious, with the majority of ratings in Sector Perform territory and a mean price target of $5.00, suggesting -4.4% downside. Our AI forecast model points to short-term weakness (-11.66% over two weeks), a medium-term fall (-99.81% over three months), and a longer-term gain (319.89% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Medical Properties Trust, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -11.66%, with price expected at $4.62 by May 01, 2026, within a range of $3.22 to $6.16 3-Month Outlook: Projected fall of -99.81%, reaching $0.01 by July 16, 2026, with a range of $0.00 to $0.22. 1-Year Outlook: Projected gain of 319.89%, with price at $21.96 by April 16, 2027, within a range of $21.65 to $22.21.

Medical Properties Trust, Inc. trades at a P/E ratio of -11.34, slightly below the S&P 500 average, with a price-to-sales ratio of 15.91 and a price-to-book ratio of 0.68 suggesting the stock is closer to book value. The P/FCF stands at 67.0, also below market averages.